Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer

Genomic studies performed through liquid biopsies widely elucidated the evolutionary trajectory of RAS mutant clones under the selective pressure of EGFR inhibitors in patients with wild type RAS primary colorectal tumors. Similarly, the disappearance of RAS mutant clones in plasma has been more rec...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancers (Basel)
Päätekijät: Raimondi, Cristina, Nicolazzo, Chiara, Belardinilli, Francesca, Loreni, Flavia, Gradilone, Angela, Mahdavian, Yasaman, Gelibter, Alain, Giannini, Giuseppe, Cortesi, Enrico, Gazzaniga, Paola
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2019
Aiheet:
Communication
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357143/
https://ncbi.nlm.nih.gov/pubmed/30621206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11010042
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia